JOE
HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Accepted Preprint first posted online on 18 August 2008

Journal of Endocrinology 2008;199:201.

Journal of Endocrinology (2008) In press
DOI: 10.1677/JOE-08-0302
© 2008 Society for Endocrinology
This Article
Right arrow Accepted manuscript (PDF)
Right arrow All Versions of this Article:
JOE-08-0302v1
199/2/201    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Myers, M.
Right arrow Articles by Duncan, W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Myers, M.
Right arrow Articles by Duncan, W.

RESEARCH

Activin A reduces luteinisation of human luteinised granulosa cells and has opposing effects to human chorionic gonadotropin (hCG) in vitro.

Michelle Myers, Sander van den Driesche, Alan McNeilly and William Duncan

M Myers, Reproductive and Developmental Sciences, University of Edinburgh, Edinburgh, United Kingdom
S van den Driesche, Reproductive and Developmental Sciences, University of Edinburgh, Edinburgh, United Kingdom
A McNeilly, MRC Human Reproductive Sciences Unit, Edinburgh, United Kingdom
W Duncan, Reproductive and Developmental Sciences, University of Edinburgh, Edinburgh, EH16 4SA, United Kingdom

Correspondence: William Duncan, Email: W.C.Duncan{at}ed.ac.uk

Abstract

The transition of the dominant follicle in the corpus luteum is of fundamental reproductive importance. Luteinisation involves disparate changes in the gene expression of follicular granulosa cells which differentiate into the granulosa-lutein cells of the corpus luteum after the gonadotrophin surge. We have shown that activin and hCG have opposing effects during luteolysis. Therefore we hypothesised that activin A was an inhibitor of luteinisation that was blocked during the preovulatory gonadotrophin surge. Ovarian tissue and cells were collected from women with regular cycles having hysterectomy and women undergoing oocyte retrieval for assisted conception. Genes that changes during luteinisation were investigated in primary cultures of luteinised granulosa cells exposed to activin A and hCG in vitro. HCG promotes a luteinised granulosa cell phenotype, whilst activin A promotes a more follicular phenotype in luteinised cells by up-regulating granulosa cells markers such as FSHR, HSD11B2 and down-regulating LHCGR. In addition activin A blocked hCG up-regulation of STAR, HSD3B1 and HSD11B1 and down-regulation of ESR1. Activin A antagonised hCG effects in a dose-dependent manner and could block the hCG stimulated molecular inhibitors of activin action (INHA, FST and TGFBR3). These studies show that hCG and activin A have opposing effects on luteinised granulosa cells and some effects of activin are only seen in the presence of hCG. While hCG can inhibit activin action in granulosa cells to facilitate luteinisation, activin A can promote an unluteinised phenotype in luteinised granulosa cells. This confirms the importance of adequate activin withdrawal during luteinisation in women.




This article has been cited by other articles:


Home page
J EndocrinolHome page
Y. Xia and A. L Schneyer
The biology of activin: recent advances in structure, regulation and function
J. Endocrinol., July 1, 2009; 202(1): 1 - 12.
[Abstract] [Full Text] [PDF]




HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2008 by the Society for Endocrinology.